Table 2.
Prevalence of generalized anxiety symptoms, depression symptoms, psychological distress and COVID-19-related fear stratified by gender
| Total | Sex | |||
|---|---|---|---|---|
| (N = 15 037) | Female (N = 10 633) | Male (N = 4353) | Inter/diverse (N = 51) | |
| GAD-7 | ||||
| <5 | 8289 (55.1%) | 5413 (50.9%) | 2853 (65.5%) | 23 (45.1%) |
| ≥5 | 4226 (28.1%) | 3173 (29.8%) | 1037 (23.8%) | 16 (31.4%) |
| ≥10 | 1476 (9.6%) | 1199 (11.3%) | 272 (6.2%) | 5 (9.8%) |
| ≥15 | 1046 (7.0%) | 848 (8.0%) | 191 (4.4%) | 7 (13.7%) |
| PHQ-2 | ||||
| <3 | 12 880 (85.7%) | 9025 (84.9%) | 3822 (87.8%) | 33 (64.7%) |
| ≥3 | 2157 (14.3%) | 1608 (15.1%) | 531 (12.2%) | 18 (35.3%) |
| DT | ||||
| <4 | 5238 (34.8%) | 3423 (32.2%) | 1797 (41.3%) | 18 (35.3%) |
| ≥4 | 9799 (65.2%) | 7210 (67.8%) | 2556 (58.7%) | 33 (64.7%) |
| COVID-19-related fear | ||||
| <5 | 6170 (41.0%) | 3942 (37.1%) | 2199 (50.5%) | 29 (56.9%) |
| ≥5 | 8867 (59.0%) | 6691 (62.9%) | 2154 (49.5%) | 22 (43.1%) |
Note: GAD-7 = Generalized Anxiety Disorder Scale-7, sum scores of ≥5, ≥10 and ≥15 indicate mild, moderate and severe generalized anxiety symptoms, respectively; PHQ-2 = Patient Health Questionnaire-2, sum scores of ≥3 indicate major depression symptoms; DT = Distress Thermometer, a score ≥4 indicates elevated psychological distress. COVID-19-related fear, ≥5 indicate elevated COVID-19-related fear.